Literature DB >> 22961023

Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting.

Jennifer L Kuntz1, Eric S Johnson, Marsha A Raebel, Amanda F Petrik, Xiuhai Yang, Micah L Thorp, Steven J Spindel, Nancy Neil, David H Smith.   

Abstract

OBJECTIVE: To describe the epidemiology and healthcare costs of Clostridium difficile infection (CDI) identified in the outpatient setting.
DESIGN: Population-based, retrospective cohort study. PATIENTS: Kaiser Permanente Colorado and Kaiser Permanente Northwest members between June 1, 2005, and September 30, 2008.
METHODS: We identified persons with incident CDI and classified CDI by whether it was identified in the outpatient or inpatient healthcare setting. We collected information about baseline variables and follow-up healthcare utilization, costs, and outcomes among patients with CDI. We compared characteristics of patients with CDI identified in the outpatient versus inpatient setting.
RESULTS: We identified 3,067 incident CDIs; 56% were identified in the outpatient setting. Few strong, independent predictors of diagnostic setting were identified, although a previous stay in a nonacute healthcare institution (odds ratio [OR], 1.45 [95% confidence interval (CI), 1.13-1.86]) was statistically associated with outpatient-identified CDI, as was age from 50 to 59 years (OR, 1.64 [95% CI, 1.18-2.29]), 60 to 69 years (OR, 1.37 [95% CI, 1.03-1.82]), and 70 to 79 years (OR, 1.36 [95% CI, 1.06-1.74]), when compared with persons aged 80-89 years.
CONCLUSIONS: We found that more than one-half of incident CDIs in this population were identified in the outpatient setting. Patients with outpatient-identified CDI were younger with fewer comorbidities, although they frequently had previous exposure to healthcare. These data suggest that practitioners should be aware of CDI and obtain appropriate diagnostic testing on outpatients with CDI symptoms.

Entities:  

Mesh:

Year:  2012        PMID: 22961023     DOI: 10.1086/667733

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  15 in total

Review 1.  The economic impact of Clostridium difficile infection: a systematic review.

Authors:  Natasha Nanwa; Tetyana Kendzerska; Murray Krahn; Jeffrey C Kwong; Nick Daneman; William Witteman; Nicole Mittmann; Suzanne M Cadarette; Laura Rosella; Beate Sander
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

Review 2.  Recent Issues in Pediatric Clostridium difficile Infection.

Authors:  Jason A Clayton; Philip Toltzis
Journal:  Curr Infect Dis Rep       Date:  2017-11-07       Impact factor: 3.725

3.  Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries.

Authors:  Christian Eckmann; Matthew Wasserman; Faisal Latif; Graeme Roberts; Axelle Beriot-Mathiot
Journal:  Eur J Health Econ       Date:  2013-10

4.  Utilization of Health Services Among Adults With Recurrent Clostridium difficile Infection: A 12-Year Population-Based Study.

Authors:  Jennifer L Kuntz; Jennifer M Baker; Patricia Kipnis; Sherian Xu Li; Vincent Liu; Yang Xie; Stephen Marcella; Gabriel J Escobar
Journal:  Infect Control Hosp Epidemiol       Date:  2016-10-20       Impact factor: 3.254

5.  Association of Dental Care with Adherence to HEDIS Measures.

Authors:  David Mosen; Dan Pihlstrom; John Snyder; Ning Smith; Elizabeth Shuster; Kristal Rust
Journal:  Perm J       Date:  2015-11-09

6.  In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.

Authors:  Hans H Locher; Peter Seiler; Xinhua Chen; Susanne Schroeder; Philippe Pfaff; Michel Enderlin; Axel Klenk; Elvire Fournier; Christian Hubschwerlen; Daniel Ritz; Ciaran P Kelly; Wolfgang Keck
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

7.  Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease.

Authors:  G Samonis; K Z Vardakas; G S Tansarli; D Dimopoulou; G Papadimitriou; D P Kofteridis; S Maraki; M Karanika; M E Falagas
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

8.  Ambulatory-treated Clostridium difficile infection: a comparison of community-acquired vs. nosocomial infection.

Authors:  T Delate; G Albrecht; K Won; A Jackson
Journal:  Epidemiol Infect       Date:  2014-07-24       Impact factor: 4.434

9.  Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.

Authors:  Samuel L Aitken; Tiby B Joseph; Dhara N Shah; Todd M Lasco; Hannah R Palmer; Herbert L DuPont; Yang Xie; Kevin W Garey
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

10.  Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT.

Authors:  David M Mosen; Elizabeth G Liles; Adrianne C Feldstein; Nancy Perrin; Anna G Rosales; Erin Keast; David H Smith
Journal:  Eur J Cancer Prev       Date:  2014-11       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.